General Fluidics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$18M
- Investors
-
2
General Fluidics General Information
Description
Developer of a vitro diagnostic tool designed for end-to-end, fully integrated modular IVD for performing a growing array of blood and urine tests. The company's tool uses a patented hybrid hardware architecture, fluidics, and optoelectronic technologies to deliver complete diagnostic information sets at the point of care and make blood diagnostics more accessible, enabling physicians to provide better treatments for neonatal and pediatric patients.
Contact Information
Website
www.generalfluidics.comCorporate Office
- 1601 Trapelo Road
- Suite 152
- Waltham, MA 02451
- United States
Corporate Office
- 1601 Trapelo Road
- Suite 152
- Waltham, MA 02451
- United States
General Fluidics Timeline
General Fluidics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Debt - General | 01-Mar-2026 | $18M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series B) | 31-Jul-2024 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 15-Dec-2020 | $12M | $12M | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2014 | $224K | Completed | Startup |
General Fluidics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
General Fluidics Patents
General Fluidics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260126372-A1 | Flow cytometer module and methods of use thereof | Pending | 07-Nov-2024 | ||
| WO-2026102331-A2 | Flow cytometer module and methods of use thereof | Pending | 07-Nov-2024 | ||
| WO-2026102331-A3 | Flow cytometer module and methods of use thereof | Pending | 07-Nov-2024 | ||
| US-20260126459-A1 | Module for detecting or measuring analytes in fluid | Pending | 07-Nov-2024 | ||
| WO-2026102328-A1 | Module for detecting or measuring analytes in fluid | Pending | 07-Nov-2024 | G01N35/00584 |
General Fluidics Signals
General Fluidics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kendall Capital Partners | Venture Capital | Minority | ||
| U.S. Department of Health and Human Services | Government |
General Fluidics FAQs
-
When was General Fluidics founded?
General Fluidics was founded in 2013.
-
Where is General Fluidics headquartered?
General Fluidics is headquartered in Waltham, MA.
-
What is the size of General Fluidics?
General Fluidics has 13 total employees.
-
What industry is General Fluidics in?
General Fluidics’s primary industry is Diagnostic Equipment.
-
Is General Fluidics a private or public company?
General Fluidics is a Private company.
-
What is General Fluidics’s current revenue?
The current revenue for General Fluidics is .
-
How much funding has General Fluidics raised over time?
General Fluidics has raised $52.6M.
-
Who are General Fluidics’s investors?
Kendall Capital Partners and U.S. Department of Health and Human Services have invested in General Fluidics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process